Quick answer
Chronic kidney disease (CKD) affects about 1 in 7 American adults—35.5 million people. Most don't know they have it until significant damage is done.
New research from UC Davis, published in Science, reveals a hidden accelerant: gut bacteria producing a toxin that worsens kidney damage in a self-reinforcing cycle.
The Destructive Loop
Here's what researchers discovered:
- Kidney dysfunction causes the colon's mucous layer to produce more of an enzyme called iNOS (inducible nitric oxide synthase)
- More iNOS leads to more nitric oxide, which reacts with oxygen radicals to form nitrate
- Higher nitrate levels fuel the growth of E. coli and other Enterobacteriaceae bacteria
- These bacteria produce indole, which the liver converts to indoxyl sulfate—a kidney toxin
- Indoxyl sulfate damages kidneys further, restarting the cycle
It's a feedback loop where sicker kidneys alter the gut environment, which produces toxins that make kidneys sicker.
The Toxin Dialysis Can't Remove
Indoxyl sulfate is particularly insidious because it binds to albumin, a common blood protein. Hemodialysis can't remove it effectively.
Higher serum indoxyl sulfate levels correlate with more severe chronic kidney disease. So even patients on dialysis face continued accumulation of this gut-derived toxin.
The Mouse Evidence
Researchers tested specific E. coli strains in mice with kidney disease. They found:
- Kidney dysfunction increased transcription of Nos2 (the gene that creates iNOS) in the colon
- Elevated iNOS drove nitrate production
- Higher nitrate boosted E. coli growth and indoxyl sulfate production
- The loop accelerated kidney damage
Human Confirmation
Fecal samples from people with CKD showed the same pattern: higher E. coli levels than healthy controls.
Crucially, indole production only spiked when nitrate was added—matching the mouse findings. The nitrate appears to be the trigger that converts harmless gut bacteria into indole producers.
A Potential Treatment
The researchers tested aminoguanidine, an investigational drug that inhibits iNOS. Mice given the drug showed:
- Reduced mucous nitrate
- Lowered indoxyl sulfate
- Improved kidney outcomes
This suggests targeting the gut environment—not just the kidneys—might help slow CKD progression.
What This Means for You
If you have kidney disease or risk factors (diabetes, high blood pressure), the gut-kidney axis matters:
- Diet matters: High-fiber diets may help reduce Enterobacteriaceae overgrowth by promoting beneficial bacteria
- Avoid unnecessary antibiotics: Disrupting the microbiome can allow pathogenic bacteria to expand
- Watch protein intake: Excessive protein increases nitrogenous waste products the kidneys must filter
- Consider probiotics cautiously: Some strains may help, but evidence is still emerging
This research also underscores why CKD patients should work with nephrologists and dietitians—the gut is now clearly part of the disease equation.
The Bigger Picture
This study adds to growing evidence that organ systems don't operate in isolation. The gut influences the liver, brain, skin, heart—and now we have a clearer mechanism for how it affects kidneys too.
For the 788 million people worldwide with CKD, understanding the gut-kidney axis could open new treatment pathways. Breaking the nitrate-E. coli-indoxyl sulfate cycle might slow disease progression in ways dialysis alone cannot.
Medical disclaimer: This article is for informational purposes only. Consult a healthcare provider for kidney disease management.